实用医学杂志 ›› 2022, Vol. 38 ›› Issue (8): 953-957.doi: 10.3969/j.issn.1006⁃5725.2022.08.008

• 基础研究 • 上一篇    下一篇

BET蛋白抑制剂JQ-1对系统性红斑狼疮患者外周血B细胞分化的调控作用

李昊 曾珊 邱茜 肖游君 徐思琪 王竞男 石茂华 许韩师 梁柳琴   

  1. 中山大学附属第一医院风湿免疫科(广州510080)

  • 出版日期:2022-04-25 发布日期:2022-04-25
  • 基金资助:
    国家自然科学基金(编号:81701611);广州市民生 科技攻关计划(编号:201803010042)许韩师 E ⁃mail:xuhanshi@hotmail.com;梁   E⁃mail:lliuq@mail.sysu.edu.cn

BET protein inhibitor JQ ⁃1 regulates the differentiation of peripheral blood B cells in systemic lupus erythematosus

LI Hao,ZENG Shan,QIU Qian,XIAO Youjun,XU Siqi,WANG Jingnan,SHI Maohua,XU Hanshi,LIANG Liuqin.   

  1. Department of Rheumatology and Immunology,the First Affiliated Hospital,Sun Yat ⁃ sen University,Guangzhou 510080,China

  • Online:2022-04-25 Published:2022-04-25
  • Contact: XU Hanshi E⁃mail:xuhanshi@hotmail.com;LIANG Liuqin E⁃mail:lliuq@mail.sysu.edu.cn

摘要:

目的 探讨 BET 蛋白抑制剂 JQ⁃1 对系统性红斑狼疮(SLE)患者外周血 B 细胞分化中的作用 及机制。方法 收集 SLE 患者外周血,分离纯化 B 细胞进行实验;体外培养 SLE 患者外周血 B 细胞;应用 流式细胞术检测 SLE 患者外周血 B 细胞凋亡、存活及增殖的比例,检测外周血 B 细胞各亚群细胞的比例和 B 细胞体外诱导分化为浆母细胞的比例。结果 与对照组相比,BET 蛋白抑制剂 JQ1 SLE 外周血 B 细胞 早期凋亡、存活及增殖无影响,但可显著下调浆母细胞、浆细胞亚群的比例,使浆母细胞体外诱导分化成 浆细胞的比例减少。结论 BRD4 蛋白参与调控 SLE 患者外周血浆母细胞分化成浆细胞过程,JQ⁃1 可能 SLE 的潜在治疗药物。

关键词:

系统性红斑狼疮, B 细胞, BRD4蛋白, JQ?1

Abstract:

Objective To investigate the effect of BET protein inhibitor JQ⁃1 on the differentiation of peripheral blood B cells in systemic lupus erythematosus(SLE). Methods We collected the peripheral blood from 46 SLE patients,from which B cells were isolated,purified and cultured in vitro. Flow cytometry was used to detect the proportion of apoptosis,survival and proliferation of peripheral blood B cells,the proportion of subpopu⁃ lation cells and the proportion of B cells differentiation into plasmablasts in vitro. Results Compared with the con⁃ trol group,the BET protein inhibitor JQ1 had little effect on the early apoptosis,survival and proliferation of the peripheral blood B cells,but it significantly reduced the rates of plasmablasts and plasma cells so as to reduce the proportion of B cells differentiation into plasmablasts in vitro. Conclusion BET protein inhibitor JQ⁃1 can regu⁃ late the differentiation of peripheral plasma blasts into plasma cells in SLE patients,indicating that it may have potential therapeutic effect on SLE.

Key words: SLE,  , B cell,  , BRD4 protein,  , JQ?1